Molecular Pathways in Pulmonary Arterial Hypertension

Pulmonary arterial hypertension is a multifactorial, chronic disease process that leads to pulmonary arterial endothelial dysfunction and smooth muscular hypertrophy, resulting in impaired pliability and hemodynamics of the pulmonary vascular system, and consequent right ventricular dysfunction. Exi...

Full description

Bibliographic Details
Main Authors: Aangi J. Shah, Mounica Vorla, Dinesh K. Kalra
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/17/10001
_version_ 1797495027828523008
author Aangi J. Shah
Mounica Vorla
Dinesh K. Kalra
author_facet Aangi J. Shah
Mounica Vorla
Dinesh K. Kalra
author_sort Aangi J. Shah
collection DOAJ
description Pulmonary arterial hypertension is a multifactorial, chronic disease process that leads to pulmonary arterial endothelial dysfunction and smooth muscular hypertrophy, resulting in impaired pliability and hemodynamics of the pulmonary vascular system, and consequent right ventricular dysfunction. Existing treatments target limited pathways with only modest improvement in disease morbidity, and little or no improvement in mortality. Ongoing research has focused on the molecular basis of pulmonary arterial hypertension and is going to be important in the discovery of new treatments and genetic pathways involved. This review focuses on the molecular pathogenesis of pulmonary arterial hypertension.
first_indexed 2024-03-10T01:42:39Z
format Article
id doaj.art-c922c7d51923478d84ff8ff52fc34608
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T01:42:39Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-c922c7d51923478d84ff8ff52fc346082023-11-23T13:21:08ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-09-0123171000110.3390/ijms231710001Molecular Pathways in Pulmonary Arterial HypertensionAangi J. Shah0Mounica Vorla1Dinesh K. Kalra2Department of Internal Medicine, School of Medicine, University of Louisville, Louisville, KY 40202, USADivision of Cardiology, School of Medicine, University of Louisville, Louisville, KY 40202, USADivision of Cardiology, School of Medicine, University of Louisville, Louisville, KY 40202, USAPulmonary arterial hypertension is a multifactorial, chronic disease process that leads to pulmonary arterial endothelial dysfunction and smooth muscular hypertrophy, resulting in impaired pliability and hemodynamics of the pulmonary vascular system, and consequent right ventricular dysfunction. Existing treatments target limited pathways with only modest improvement in disease morbidity, and little or no improvement in mortality. Ongoing research has focused on the molecular basis of pulmonary arterial hypertension and is going to be important in the discovery of new treatments and genetic pathways involved. This review focuses on the molecular pathogenesis of pulmonary arterial hypertension.https://www.mdpi.com/1422-0067/23/17/10001pulmonary arterial hypertensionmolecular pathogenesisclassificationpathobiology
spellingShingle Aangi J. Shah
Mounica Vorla
Dinesh K. Kalra
Molecular Pathways in Pulmonary Arterial Hypertension
International Journal of Molecular Sciences
pulmonary arterial hypertension
molecular pathogenesis
classification
pathobiology
title Molecular Pathways in Pulmonary Arterial Hypertension
title_full Molecular Pathways in Pulmonary Arterial Hypertension
title_fullStr Molecular Pathways in Pulmonary Arterial Hypertension
title_full_unstemmed Molecular Pathways in Pulmonary Arterial Hypertension
title_short Molecular Pathways in Pulmonary Arterial Hypertension
title_sort molecular pathways in pulmonary arterial hypertension
topic pulmonary arterial hypertension
molecular pathogenesis
classification
pathobiology
url https://www.mdpi.com/1422-0067/23/17/10001
work_keys_str_mv AT aangijshah molecularpathwaysinpulmonaryarterialhypertension
AT mounicavorla molecularpathwaysinpulmonaryarterialhypertension
AT dineshkkalra molecularpathwaysinpulmonaryarterialhypertension